• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (34)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Infectious Diseases, Other  • Corneal Disorders  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Prajna Lalitha, MD; Brett L. Shapiro, BA; Muthiah Srinivasan, MD; Namperumalsamy Venkatesh Prajna, DNB, FRCOphth; Nisha R. Acharya, MD; Annette W. Fothergill, MA; Jazmin Ruiz, BS; Jaya D. Chidambaram, MBBS, MRCOphth; Kathryn J. Maxey, MS; Kevin C. Hong, BA; Stephen D. McLeod, MD; Thomas M. Lietman, MD

Arch Ophthalmol. 2007;125(6):789-793.

Objective  To characterize the susceptibility of filamentous fungi isolated from keratitis to amphotericin B, natamycin, caspofungin acetate, itraconazole, voriconazole, and posaconazole.

Methods  Ninety isolates from fungal keratitis cases at Aravind Eye Hospital in South India were tested using macrobroth dilution for susceptibility to amphotericin B, natamycin, caspofungin, itraconazole, voriconazole, and posaconazole. The minimum inhibitory concentration (MIC) median and 90th percentile were determined.

Results  The 90 isolates included 41 Aspergillus species, 38 Fusarium species, and 11 others. The triazoles and caspofungin had the lowest MICs against Aspergillus species; voriconazole, amphotericin B, and posaconazole had the lowest MICs against Fusarium species, and none of the Fusarium species were inhibited by itraconazole or caspofungin. Amphotericin B had significantly lower MICs compared with natamycin, but after correcting for the typical prescription dose, natamycin was superior.

Conclusion  No single agent was universally most effective, but voriconazole and other triazoles demonstrated the broadest spectrum. Itraconazole and caspofungin were not effective against Fusarium species.

Clinical Relevance  Fungal ulcers are commonly treated empirically; drugs are typically selected without regard to susceptibility data. The nonocular infectious disease literature suggests modern fungal susceptibility methods are clinically relevant, but ocular studies are limited. Our results suggest antifungal therapy might be tailored to individual organisms.

Author Affiliations: Aravind Eye Hospital and PG Institute of Ophthalmology, Madurai, India (Drs Lalitha, Srinivasan, and Prajna); School of Medicine (Mr Shapiro and Dr Lietman), F. I. Proctor Foundation (Messrs Shapiro and Hong, Drs Acharya, Chidambaram, McLeod, and Lietman, and Ms Maxey), Departments of Ophthalmology (Drs Acharya, McLeod, and Lietman) and Epidemiology and Biostatistics (Dr Lietman), and Institute for Global Health (Dr Lietman), University of California, San Francisco; and Department of Pathology, University of Texas Health Sciences Center, San Antonio (Mss Fothergill and Ruiz).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Prototype Antifungal Contact Lens
Ciolino et al.
IOVS 2011;52:6286-6291.
ABSTRACT | FULL TEXT  

Treatment of Alternaria Keratitis with Intrastromal and Topical Caspofungin in Combination with Intrastromal, Topical, and Oral Voriconazole
Neoh et al.
The Annals of Pharmacotherapy 2011;45:e24-e24.
ABSTRACT | FULL TEXT  

Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis
Lalitha et al.
Br J Ophthalmol 2011;95:744-745.
FULL TEXT  

Penetration of Topically Administered 0.5-Percent Caspofungin Eye Drops into Human Aqueous Humor
Neoh et al.
Antimicrob. Agents Chemother. 2011;55:1761-1763.
ABSTRACT | FULL TEXT  

Evaluating Retinal Toxicity of Intravitreal Caspofungin in the Mouse Eye
Mojumder et al.
IOVS 2010;51:5796-5803.
ABSTRACT | FULL TEXT  

Comparison of Natamycin and Voriconazole for the Treatment of Fungal Keratitis
Prajna et al.
Arch Ophthalmol 2010;128:672-678.
ABSTRACT | FULL TEXT  

Susceptibility testing and clinical outcome in fungal keratitis
Shapiro et al.
Br J Ophthalmol 2010;94:384-385.
FULL TEXT  

In Vitro Activity of Thimerosal against Ocular Pathogenic Fungi
Xu et al.
Antimicrob. Agents Chemother. 2010;54:536-539.
ABSTRACT | FULL TEXT  

Utility of Molecular Sequence Analysis of the ITS rRNA Region for Identification of Fusarium spp. from Ocular Sources
Oechsler et al.
IOVS 2009;50:2230-2236.
ABSTRACT | FULL TEXT  

Activity of antibiotics against Fusarium and Aspergillus
Day et al.
Br J Ophthalmol 2009;93:116-119.
ABSTRACT | FULL TEXT  

In Vitro Natamycin Susceptibility of Ocular Isolates of Fusarium and Aspergillus Species: Comparison of Commercially Formulated Natamycin Eye Drops to Pharmaceutical-Grade Powder
Lalitha et al.
J. Clin. Microbiol. 2008;46:3477-3478.
ABSTRACT | FULL TEXT